NBC Securities Inc. lowered its stake in shares of Baxter International Inc. (NYSE:BAX – Free Report) by 18.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,349 shares of the medical instruments supplier’s stock after selling 300 shares during the period. NBC Securities Inc.’s holdings in Baxter International were worth $51,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of the stock. Valeo Financial Advisors LLC bought a new stake in Baxter International in the third quarter worth approximately $218,000. Livforsakringsbolaget Skandia Omsesidigt boosted its position in Baxter International by 229.9% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 4,747 shares of the medical instruments supplier’s stock worth $180,000 after purchasing an additional 3,308 shares during the period. First PREMIER Bank acquired a new position in Baxter International during the third quarter valued at approximately $25,000. GAMMA Investing LLC lifted its stake in shares of Baxter International by 6.5% in the third quarter. GAMMA Investing LLC now owns 7,517 shares of the medical instruments supplier’s stock worth $285,000 after buying an additional 459 shares during the last quarter. Finally, Handelsbanken Fonder AB boosted its holdings in shares of Baxter International by 8.7% during the 3rd quarter. Handelsbanken Fonder AB now owns 217,629 shares of the medical instruments supplier’s stock worth $8,263,000 after buying an additional 17,450 shares during the period. 90.19% of the stock is currently owned by hedge funds and other institutional investors.
Baxter International Trading Up 0.6 %
Shares of BAX stock opened at $36.86 on Monday. The firm has a fifty day moving average of $37.61 and a 200-day moving average of $36.58. The stock has a market cap of $18.78 billion, a price-to-earnings ratio of 7.09, a P/E/G ratio of 1.28 and a beta of 0.59. Baxter International Inc. has a 52-week low of $31.70 and a 52-week high of $44.01. The company has a debt-to-equity ratio of 1.35, a quick ratio of 0.91 and a current ratio of 1.40.
Analysts Set New Price Targets
A number of research analysts have weighed in on the stock. The Goldman Sachs Group boosted their target price on shares of Baxter International from $36.00 to $40.00 and gave the stock a “neutral” rating in a research report on Thursday, August 8th. StockNews.com cut Baxter International from a “buy” rating to a “hold” rating in a research report on Tuesday, October 1st. Evercore ISI lowered their target price on Baxter International from $46.00 to $45.00 and set an “outperform” rating on the stock in a report on Tuesday, July 2nd. Morgan Stanley cut Baxter International from an “equal weight” rating to an “underweight” rating and reduced their price objective for the company from $39.00 to $30.00 in a research report on Monday, July 15th. Finally, Wells Fargo & Company dropped their target price on shares of Baxter International from $44.00 to $40.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Baxter International presently has an average rating of “Hold” and an average price target of $42.00.
Check Out Our Latest Stock Analysis on BAX
Baxter International Profile
Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.
Featured Stories
- Five stocks we like better than Baxter International
- Why Are Stock Sectors Important to Successful Investing?
- Is Spotify Stock Poised to Soar? Options Traders Think So
- How to Most Effectively Use the MarketBeat Earnings Screener
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Stock Splits, Do They Really Impact Investors?
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX – Free Report).
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.